Related references
Note: Only part of the references are listed.Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin
Beatriz E. Ferro et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
R. Andres Floto et al.
THORAX (2016)
Long-term Follow-up of Mycobacterium avium Complex Lung Disease in Patients Treated With Regimens Including Clofazimine and/or Rifampin
Julie Jarand et al.
CHEST (2016)
Improvement in Quality of Life after Therapy for Mycobacterium abscessus Group Lung Infection A Prospective Cohort Study
Christopher A. Czaja et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2016)
Semiquantitative Culture Analysis during Therapy for Mycobacterium avium Complex Lung Disease
David E. Griffith et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Intermittent Antibiotic Therapy for Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease
Byeong-Ho Jeong et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Comparison of Clinical Features, Virulence, and Relapse among Mycobacterium avium Complex Species
Daniel P. Boyle et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Response to Switch from Intermittent Therapy to Daily Therapy for Refractory Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease
Won-Jung Koh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Risk Factors for Recurrence after Successful Treatment of Mycobacterium avium Complex Lung Disease
Bo Young Lee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
The Significance of Mycobacterium abscessus Subspecies abscessus Isolation During Mycobacterium avium Complex Lung Disease Therapy
David E. Griffith et al.
CHEST (2015)
Preliminary Results of Bedaquiline as Salvage Therapy for Patients With Nontuberculous Mycobacterial Lung Disease
Julie V. Philley et al.
CHEST (2015)
Rapidly growing mycobacteria in Singapore, 2006-2011
S. S. Tang et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
The Treatment of Rapidly Growing Mycobacterial Infections
Shannon H. Kasperbauer et al.
CLINICS IN CHEST MEDICINE (2015)
Treatment of Slowly Growing Mycobacteria
Julie V. Philley et al.
CLINICS IN CHEST MEDICINE (2015)
Microbiological Diagnosis of Nontuberculous Mycobacterial Pulmonary Disease
Jakko van Ingen
CLINICS IN CHEST MEDICINE (2015)
Epidemiology of Human Pulmonary Infection with Nontuberculous Mycobacteria A Review
D. Rebecca Prevots et al.
CLINICS IN CHEST MEDICINE (2015)
The drug susceptibility profile and inducible resistance to macrolides of Mycobacterium abscessus and Mycobacterium massiliense in Korea
Song Yee Kim et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2015)
The tolerability of linezolid in the treatment of nontuberculous mycobacterial disease
Kevin L. Winthrop et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Determinants of recurrence after successful treatment of Mycobacterium avium complex lung disease
J. Min et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2015)
New Real-Time PCR Assays for Detection of Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus Group
Shamira J. Shallom et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
Utility of Sequencing the erm(41) Gene in Isolates of Mycobacterium abscessus subsp abscessus with Low and Intermediate Clarithromycin MICs
Barbara A. Brown-Elliott et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients
Anne-Laure Roux et al.
JOURNAL OF CYSTIC FIBROSIS (2015)
Epidemiology and Clinical Features of Pulmonary Nontuberculous Mycobacteriosis in Nagasaki, Japan
Shotaro Ide et al.
PLOS ONE (2015)
Clinical Significance of Mycobacterium kansasii Isolates from Respiratory Specimens
Seong Mi Moon et al.
PLOS ONE (2015)
Variable agreement among experts regarding Mycobacterium avium complex lung disease
Theodore K. Marras et al.
RESPIROLOGY (2015)
Mycobacterium abscessus Pleased to Meet You, Hope You Guess My Name...
David E. Griffith et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2015)
Macrolide/Azalide Therapy for Nodular/Bronchiectatic Mycobacterium avium Complex Lung Disease
Richard J. Wallace et al.
CHEST (2014)
Microbiological Features and Clinical Relevance of New Species of the Genus Mycobacterium
Enrico Tortoli
CLINICAL MICROBIOLOGY REVIEWS (2014)
Treatment outcomes for Mycobacterium avium complex: a systematic review and meta-analysis
H. -B. Xu et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2014)
Drug susceptibility testing of nontuberculous mycobacteria
Jakko van Ingen et al.
FUTURE MICROBIOLOGY (2014)
Species identification of Mycobacterium abscessus subsp abscessus and Mycobacterium abscessus subsp bolletii using rpoB and hsp65, and susceptibility testing to eight antibiotics
Wenjuan Nie et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2014)
Advances in the management of pulmonary disease due to Mycobacterium abscessus complex
W-J. Koh et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2014)
Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections
Richard J. Wallace et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Erm(41)-dependent inducible resistance to azithromycin and clarithromycin in clinical isolates of Mycobacterium abscessus
Florian P. Maurer et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Detection and Assessment of Clarithromycin Inducible Resistant Strains Among Korean Mycobacterium abscessus Clinical Strains: PCR Methods
Seung-Heon Lee et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2014)
Treatment outcomes of refractory MAC pulmonary disease treated with drugs with unclear efficacy
Kyung-Wook Jo et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2014)
A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease
Jiwon Lyu et al.
RESPIRATORY MEDICINE (2014)
Pulmonary Infection and Colonization with Nontuberculous Mycobacteria, Taiwan, 2000-2012
Jung-Yien Chien et al.
EMERGING INFECTIOUS DISEASES (2014)
Diagnosis of Pulmonary Tuberculosis and Nontuberculous Mycobacterial Lung Disease in Korea
Yong Soo Kwon et al.
TUBERCULOSIS AND RESPIRATORY DISEASES (2014)
Treatment of Refractory Mycobacterium avium Complex Lung Disease with a Moxifloxacin-Containing Regimen
Won-Jung Koh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples An NTM-NET collaborative study
Wouter Hoefsloot et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Drug treatment of pulmonary nontuberculous mycobacterial disease in HIV-negative patients: the evidence
Jakko van Ingen et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2013)
Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan
Chien-Wen Huang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
In Vitro Activity of Amikacin against Isolates of Mycobacterium avium Complex with Proposed MIC Breakpoints and Finding of a 16S rRNA Gene Mutation in Treated Isolates
Barbara A. Brown-Elliott et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Update on the Epidemiology of Pulmonary Nontuberculous Mycobacterial Infections Preface
Brian A. Kendall et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Recent progress towards understanding genetic variation in the Mycobacterium abscessus complex
Susan T. Howard
TUBERCULOSIS (2013)
Pulmonary Nontuberculous Mycobacterial Disease, Ontario, Canada, 1998-2010
Theodore K. Marras et al.
EMERGING INFECTIOUS DISEASES (2013)
Increasing Recovery of Nontuberculous Mycobacteria from Respiratory Specimens over a 10-Year Period in a Tertiary Referral Hospital in South Korea
Won-Jung Koh et al.
TUBERCULOSIS AND RESPIRATORY DISEASES (2013)
Macrolide Treatment for Mycobacterium abscessus and Mycobacterium massillense Infection and Inducible Resistance
Go-Eun Choi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Prevalence of Nontuberculous Mycobacterial Lung Disease in US Medicare Beneficiaries
Jennifer Adjemian et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
The Pharmacokinetics and Pharmacodynamics of Pulmonary Mycobacterium avium Complex Disease Treatment
Jakko van Ingen et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Therapeutic Drug Monitoring in the Treatment of Mycobacterium avium Complex Lung Disease
Won-Jung Koh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
In Vitro Synergy between Clofazimine and Amikacin in Treatment of Nontuberculous Mycobacterial Disease
Jakko van Ingen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Therapy of refractory nontuberculous mycobacterial lung disease
David E. Griffith et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2012)
Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria
Jakko van Ingen et al.
DRUG RESISTANCE UPDATES (2012)
Acquisition of clarithromycin resistance mutations in the 23S rRNA gene of Mycobacterium abscessus in the presence of inducible erm(41)
Florian P. Maurer et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Clinical and Microbiological Differences between Mycobacterium abscessus and Mycobacterium massiliense Lung Diseases
Toshiyuki Harada et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Relationship between clinical efficacy for pulmonary MAC and drug-sensitivity test for isolated MAC in a recent 6-year period
Yoshihiro Kobashi et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2012)
Clinical Significance of Differentiation of Mycobacterium massiliense from Mycobacterium abscessus
Won-Jung Koh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Assessment of Clarithromycin Susceptibility in Strains Belonging to the Mycobacterium abscessus Group by erm(41) and rrl Sequencing
Sylvaine Bastian et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary Disease
Julie Jarand et al.
CLINICAL INFECTIOUS DISEASES (2011)
Outcomes in patients with Mycobacterium abscessus pulmonary disease treated with long-term injectable drugs
Jiwon Lyu et al.
RESPIRATORY MEDICINE (2011)
Increasing reports of non-tuberculous mycobacteria in England, Wales and Northern Ireland, 1995-2006
Jonathan E. Moore et al.
BMC PUBLIC HEALTH (2010)
High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria
Gwan-Han Shen et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Antibiotic Treatment of Mycobacterium abscessus Lung Disease A Retrospective Analysis of 65 Patients
Kyeongman Jeon et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
A Novel Gene, erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but Is Absent from Mycobacterium chelonae
Kevin A. Nash et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
When and how to treat pulmonary non-tuberculous mycobacterial diseases
Rachel M. Thomson et al.
RESPIROLOGY (2009)
In vitro and in vivo activities of novel Fluoroquinolones alone and in combination with clarithromycin against clinically isolated Mycobactetium avium complex strains in Japandel
Yoshihisa Kohno et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases
David E. Griffith et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease
Yoshihiro Kobashi et al.
RESPIRATORY MEDICINE (2007)
Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease
David E. Griffith et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease
Phung K. Lam et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004 -: Clinical features, drug susceptibility, and outcome
D Shitrit et al.
CHEST (2006)
Ethambutol ocular toxicity in treatment regimens for Mycobacterium avium complex lung disease
DE Griffith et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Mycobacterium avium complex pulmonary disease in patients without HIV infection
SK Field et al.
CHEST (2004)
Treatment of Mycobacterium avium-intracellulare complex lung disease with a macrolide, ethambutol, and clofazimine
SK Field et al.
CHEST (2003)
Thrice-weekly clarithromycin-containing regimen for treatment of Mycobacterium kansasii lung disease: Results of a preliminary study
DE Griffith et al.
CLINICAL INFECTIOUS DISEASES (2003)
Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex
DE Griffith et al.
CLINICAL INFECTIOUS DISEASES (2000)
Share Paper
